News & Updates

Taking vitamin D supplements does not appear to help reduce the risk of acute respiratory infections (ARIs) contrary to previous report, according to an updated meta-analysis.

A recent study has shown the inverse associations of plasma phospholipid proportions of linoleic acid (LA) and α-linolenic acid (ALA), biomarkers of vegetable oil intake, during childhood and adolescence with measures of obesity and cardiometabolic health in young adulthood. A potential sex difference has also been observed.

Increased consumption of lignans, specifically secoisolariciresinol (SECO), results in a significant reduction in overall cardiovascular disease (CVD) and cancer mortality among individuals with type 2 diabetes (T2D), a study has shown.

Patients taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs), particularly those with type 2 diabetes (T2D), have very low rates of retained gastric contents during endoscopy, as shown in a study.

Data from the CARDIA study demonstrate that replacing sedentary time with light-intensity physical activity (LPA) is associated with improved cardiometabolic outcomes.

The use of glucagon-like peptide 1 receptor agonists (GLP-1 RA), compared with metformin, results in a significant decrease in the incidence of primary open-angle glaucoma (POAG), ocular hypertension, and the need for first-line glaucoma treatments in patients with type 2 diabetes (T2D), reports a study.

New drug applications approved by US FDA as of 16-28 February 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.